Amanote Research

Amanote Research

    RegisterSign In

Deflazacort Versus Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta‐analysis of Disease Progression Rates in Recent Multicenter Clinical Trials

Muscle and Nerve - United States
doi 10.1002/mus.26736
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular NeuroscienceNeurologyPhysiologyCellular
Date

November 7, 2019

Authors
Craig M. McDonaldGautam SajeevZhiwen YaoErin McDonnellGary ElfringMarcio SouzaStuart W. PeltzBasil T. DarrasPerry B. ShiehDavid A. CoxJohn LandryJames Signorovitch
Publisher

Wiley


Related search

Steroids in Duchenne Muscular Dystrophy: From Clinical Trials to Genomic Research

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2002English

Randomized, Blinded Trial of Weekend vs Daily Prednisone in Duchenne Muscular Dystrophy

Neurology
Neurology
2011English

Motor Clinical Progression in a Series of Pediatric Duchenne and Becker Muscular Dystrophy Cases

Paediatrica Indonesiana
2019English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

No Sex Difference in Mutations Rates of Duchenne Muscular Dystrophy.

Journal of Medical Genetics
Genetics
1980English

“Watching Time Tick By…”: Decision Making for Duchenne Muscular Dystrophy Trials

Contemporary Clinical Trials
MedicinePharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy